» Articles » PMID: 37475124

Mitigating Neurological, Cognitive, and Psychiatric Sequelae of COVID-19-related Critical Illness

Overview
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2023 Jul 20
PMID 37475124
Authors
Affiliations
Soon will be listed here.
Abstract

Despite advances in the treatment and mitigation of critical illness caused by infection with SARS-CoV-2, millions of survivors have a devastating, post-acute infection syndrome known as long COVID. A large proportion of patients with long COVID have nervous system dysfunction, which is also seen in the distinct but overlapping condition of post-intensive care syndrome (PICS), putting survivors of COVID-19-related critical illness at high risk of long-lasting morbidity affecting multiple organ systems and, as a result, engendering measurable deficits in quality of life and productivity. In this Series paper, we discuss neurological, cognitive, and psychiatric sequelae in patients who have survived critical illness due to COVID-19. We review current knowledge of the epidemiology and pathophysiology of persistent neuropsychological impairments, and outline potential preventive strategies based on safe, evidence-based approaches to the management of pain, agitation, delirium, anticoagulation, and ventilator weaning during critical illness. We highlight priorities for current and future research, including possible therapeutic approaches, and offer considerations for health services to address the escalating health burden of long COVID.

Citing Articles

Estimated prevalence of post-intensive care cognitive impairment at short-term and long-term follow-ups: a proportional meta-analysis of observational studies.

Ho M, Lee Y, Wang L Ann Intensive Care. 2025; 15(1):3.

PMID: 39792310 PMC: 11723879. DOI: 10.1186/s13613-025-01429-z.


Omics-based analysis of mitochondrial dysfunction and BBB integrity in post-COVID-19 sequelae.

Dhariwal R, Dave K, Jain M Sci Rep. 2024; 14(1):31016.

PMID: 39730725 PMC: 11681072. DOI: 10.1038/s41598-024-82180-6.


Effects of traditional Chinese exercises or their integration with medical treatments on cognitive impairment: a network meta-analysis based on randomized controlled trials.

Qiu J, Kim S Front Aging Neurosci. 2024; 16:1475406.

PMID: 39588513 PMC: 11586772. DOI: 10.3389/fnagi.2024.1475406.


Characterization of Change in Cognition Before and After COVID-19 Infection in Essential Workers at Midlife.

Sekendiz Z, Morozova O, Carr M, Fontana A, Mehta N, Ali A Am J Med Open. 2024; 12:100076.

PMID: 39498311 PMC: 11533481. DOI: 10.1016/j.ajmo.2024.100076.


Socio-demographic and clinical predictors of post-acute, mid-and long-term psychological sequelae of COVID-19: a two-year cross-sectional investigation on 1317 patients at the University Hospital of Verona.

Perlini C, Marcanti M, Zonta M, Mazzi M, Mason A, Apollonio M Arch Public Health. 2024; 82(1):198.

PMID: 39482728 PMC: 11526637. DOI: 10.1186/s13690-024-01426-x.


References
1.
Pandharipande P, Girard T, Jackson J, Morandi A, Thompson J, Pun B . Long-term cognitive impairment after critical illness. N Engl J Med. 2013; 369(14):1306-16. PMC: 3922401. DOI: 10.1056/NEJMoa1301372. View

2.
Choutka J, Jansari V, Hornig M, Iwasaki A . Unexplained post-acute infection syndromes. Nat Med. 2022; 28(5):911-923. DOI: 10.1038/s41591-022-01810-6. View

3.
Iwasaki A, Putrino D . Why we need a deeper understanding of the pathophysiology of long COVID. Lancet Infect Dis. 2023; 23(4):393-395. PMC: 9928485. DOI: 10.1016/S1473-3099(23)00053-1. View

4.
Girard T, Exline M, Carson S, Hough C, Rock P, Gong M . Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness. N Engl J Med. 2018; 379(26):2506-2516. PMC: 6364999. DOI: 10.1056/NEJMoa1808217. View

5.
Davis H, Assaf G, McCorkell L, Wei H, Low R, Reem Y . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021; 38:101019. PMC: 8280690. DOI: 10.1016/j.eclinm.2021.101019. View